Therefore, we collected serum samples from participants who had received three doses of either of the original monovalent mRNA vaccines followed by one dose of a bivalent vaccine targeting BA.4–BA.5 ...

In a recent study published in The Lancet Regional Health Western Pacific, researchers compare the immunogenicity, reactogenicity, and safety of a half-dose Pfizer-BioNTech BNT162b2 coronavirus ...